On this page of StockholderLetter.com we present the latest annual shareholder letter from InnovAge Holding Corp. — ticker symbol INNV. Reading current and past INNV letters to shareholders can bring important insights into the investment thesis.

ANNUAL REPORT 2025 Annual Meeting The Annual Meeting will be held on Thursday, December 4, 2025 at 9:00 AM ET, via live audio webcast at www.virtualshareholdermeeting.com/INNV2025 Stockholders will be able to submit questions and vote electronically during the meeting by logging in using the 16-digit control number included on the Notice of Internet Availability of Proxy Materials, proxy card or voting instruction form. Board of Directors James Carlson Chair of the Board Patty Fontneau Director Teresa Sparks Director John Ellis Bush Director Ted Kennedy, Jr. Director Marilyn Tavenner Director Andrew Cavanna Director Thomas Scully Director Richard Zoretic Director Michael Scarbrough President and Chief Operating Officer Nicole D Amato Chief Legal Officer and Corporate Secretary Executive Officers Patrick Blair Chief Executive Officer Benjamin Adams Chief Financial Officer Common Stock Listed (INNV) NASDAQ Stock Exchange Meredith Delk Chief Administrative Officer Independent Accountants Deloitte & Touche LLP 1601 Wewatta Street, Suite 400 Denver, CO 80203 (303) 292-5400 www.deloitte.com Transfer Agent Equiniti Trust Company LLC Attn: Shareholder Services 1110 Centre Point Curve, Suite 101 Mendota Heights, MN 55120-4100 Phone: (800) 937-5449 or (718) 921-8124 Email: helpAST@equiniti.com Website: www.equiniti.com

 • shareholder letter icon 10/23/2025 Letter Continued (Full PDF)
 • stockholder letter icon 10/27/2023 INNV Stockholder Letter
 • stockholder letter icon 10/25/2024 INNV Stockholder Letter
 • stockholder letter icon More "Diagnostics" Category Stockholder Letters
 • Benford's Law Stocks icon INNV Benford's Law Stock Score = 86


INNV Shareholder/Stockholder Letter Transcript:



ANNUAL
REPORT
2025
Annual Meeting
The Annual Meeting will be held on Thursday, December 4, 2025 at 9:00 AM ET,
via live audio webcast at www.virtualshareholdermeeting.com/INNV2025
Stockholders will be able to submit questions and vote electronically during the meeting by logging in using
the 16-digit control number included on the Notice of Internet Availability of Proxy Materials, proxy card or
voting instruction form.
Board of Directors
James Carlson
Chair of the Board
Patty Fontneau
Director
Teresa Sparks
Director
John Ellis Bush
Director
Ted Kennedy, Jr.
Director
Marilyn Tavenner
Director
Andrew Cavanna
Director
Thomas Scully
Director
Richard Zoretic
Director
Michael Scarbrough
President and Chief
Operating Officer
Nicole D   Amato
Chief Legal Officer and
Corporate Secretary
Executive Officers
Patrick Blair
Chief Executive Officer
Benjamin Adams
Chief Financial Officer
Common Stock Listed (INNV)
NASDAQ Stock Exchange
Meredith Delk
Chief Administrative Officer
Independent Accountants
Deloitte & Touche LLP
1601 Wewatta Street, Suite 400
Denver, CO 80203
(303) 292-5400
www.deloitte.com
Transfer Agent
Equiniti Trust Company LLC
Attn: Shareholder Services
1110 Centre Point Curve, Suite 101
Mendota Heights, MN 55120-4100
Phone: (800) 937-5449 or (718) 921-8124
Email: helpAST@equiniti.com
Website: www.equiniti.com





shareholder letter icon 10/23/2025 Letter Continued (Full PDF)
 

INNV Stockholder/Shareholder Letter (InnovAge Holding Corp.) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.